PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $126,000 | -89.2% | 20,261 | -90.1% | 0.00% | -100.0% |
| Q3 2015 | $1,169,000 | -41.4% | 204,462 | -23.5% | 0.00% | -33.3% |
| Q2 2015 | $1,994,000 | +159.3% | 267,245 | +107.9% | 0.00% | +200.0% |
| Q1 2015 | $769,000 | -63.1% | 128,573 | -55.4% | 0.00% | -75.0% |
| Q4 2014 | $2,086,000 | +5115.0% | 288,458 | +3512.5% | 0.00% | – |
| Q3 2013 | $40,000 | +81.8% | 7,985 | +58.5% | 0.00% | – |
| Q2 2013 | $22,000 | – | 5,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,583,925 | $8,007,000 | 1.48% |
| Phocas Financial Corp. | 1,022,708 | $5,169,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,776,490 | $8,980,000 | 0.32% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,350,000 | $37,154,000 | 0.28% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 716,880 | $3,624,000 | 0.23% |
| J. Goldman & Co LP | 499,698 | $2,526,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 1,257,098 | $6,355,000 | 0.15% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $19,957,000 | 0.14% |
| EAGLE ASSET MANAGEMENT INC | 4,504,094 | $22,768,000 | 0.12% |
| Worth Venture Partners, LLC | 32,956 | $167,000 | 0.10% |